Vincenza Snow, MD; Patricia Barry, MD, MPH; Nick Fitterman, MD; Amir Qaseem, MD, PhD, MHA; Kevin Weiss, MD, MPH; Clinical Efficacy Assessment Subcommittee of the American College of Physicians*
This guideline is based on the evidence report and accompanying background papers developed by the Southern California Evidence-Based Practice Center. The American College of Physicians nominated this topic to the Agency for Healthcare Research and Quality Evidence-Based Practice Center program as part of a concerted effort to complement the guidelines of the U.S. Preventive Services Task Force. The College recommends that all clinicians refer to the Task Force recommendations as part of an overall strategy for managing overweight and obesity, which should always include appropriate diet and exercise for all patients who are overweight or obese. The intent of this guideline is to provide recommendations based on a review of the evidence on pharmacologic and surgical treatments of obesity. The target audience is all clinicians caring for obese patients, defined as a body mass index of 30 kg/m2 or greater. This guideline is not intended to be used by commercial weight loss centers or for direct-to-consumer marketing by manufacturers and does not apply to patients with body mass indices below 30 kg/m2.
*This paper, written by Vincenza Snow, MD; Patricia Barry, MD, MPH; Nick Fitterman, MD; Amir Qaseem, MD, PhD, MHA; and Kevin Weiss, MD, MPH, was developed for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians (ACP): Kevin Weiss, MD, MPH (Chair); Mark Aronson, MD; Patricia Barry, MD, MPH; Donald E. Casey Jr., MD, MPH, MBA; J. Thomas Cross Jr., MD, MPH; Nick Fitterman, MD; E. Rodney Hornbake, MD; Douglas K. Owens, MD; and Katherine D. Sherif, MD. Approved by the ACP Board of Regents in October 2004.
BMI = body mass index. *References 13-15. †U.S. Preventive Services Task Force recommendations (11, 12). ‡Assess side effects and efficacy; no data are available past 12 months except for orlistat.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Video News Release - New Treatment Guidelines for Physicians with Patients Battling Obesity
Raymond E. Bourey
Regional Center for Sleep Medicine
April 8, 2005
Treatment of Sleep Disorders May Be Essential in Some Patients with Obesity
As an endocrinologist who is also board-certified and working full- time in sleep medicine, I have long observed that many obese patients who are unable to lose weight with efforts at diet and exercise suffer from the complications of sleep apnea and/or inadequate sleep. A growing body of clinical and basic research supports a relationship between sleep disorders, weight gain, and insulin-resistance. Beyond the complex hormonal and physiological basis for the this relationship, it is reasonable to simply assume that patients who suffer the decreased mental alertness of sleep deprivation will have trouble fighting strong, natural pressures toward sloth and gluttony.
Before consideration of drugs, many of which can further compromise sleep quality, and surgical procedures and their attendant complications, I would urge clinicians to simply screen for sleep disturbances. Does the patient snore? Do they have insufficient time for sleep? Morbidly obese patients have such a high incidence of sleep apnea, that many surgical programs for obesity require pre-operative sleep studies.
A sleep evaluation and appropriate treatment for a sleep disorder may be sufficient to provide the physiological "boost" needed for a successful program of diet and exercise which in turn will avoid the complexity, expense, and dangers of drugs and surgical procedures.
Raymond E. Bourey, MD, FACP, FACE, DABSM Clinical Ass't. Professor of Medicine Medical College of Ohio Sleep Medicine and Metabolism
Medical Director The Regional Center for Sleep Medicine 4041 West Sylvania Ave., Ste 202 Toledo, OH 43623 USA 1 419 292-1616 ph 1 419 472-2193 FAX
Snow V, Barry P, Fitterman N, Qaseem A, Weiss K, Clinical Efficacy Assessment Subcommittee of the American College of Physicians*. Pharmacologic and Surgical Management of Obesity in Primary Care: A Clinical Practice Guideline from the American College of Physicians. Ann Intern Med. 2005;142:525-531. doi: 10.7326/0003-4819-142-7-200504050-00011
Download citation file:
Published: Ann Intern Med. 2005;142(7):525-531.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only